Respiratory Inhalers Market Overview:
Industrialization, air pollution and smoking has resulted in an indefinite increase in environmental pollution thereby giving birth to different respiratory ailments such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. The global respiratory inhalers market is on high pace owing to rapid increase in respiratory diseases. Respiratory inhalers have been created to counter such respiratory disorders. They are medical devices which are used for helping patients experiencing breathing problems occurring from respiratory disorders such as ARDS (acute respiratory distress syndrome), COPD, asthma and fibrosis.
There are key drivers that is driving the growth of the respiratory inhalers market. Some of the market trends and factors in this market as per an analysis conducted by Market Research Future (MRFR) include unhealthy lifestyle, increase in pollution, rising use of combination therapies owing to associated perks such as increased efficacy and easy reimbursement policies. However, there are some restraints that is restricting the growth of the respiratory inhalers market such as complications and side effects during inhalation, lack of accuracy and increasing prices of devices. The global respiratory inhalers market is anticipated to grow at a splendid 6.1% CAGR during the assessment period (2017-2023).
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3110
Respiratory Inhalers Market Segmentation:
In MFRF’s report, the global respiratory inhalers market is segmented on the basis of type, product, application and end-user.
The worldwide market for asthma inhaler devices has been trifurcated. All these three segments have a sub-segment each respectively and they have been listed as below:
- End users – Research institutes, hospitals and clinics.
- Device types – MDI with a spacer, metered dose inhaler and dry powder inhaler. Amongst these, meter dose inhaler grabs the largest chunk of the market share with around 70%.
- Technologies – Digitally operated inhaler devices and manually operated inhaler devices.
Respiratory Inhalers Market Geographical Analysis:
The asthma inhaler devices market has its reach across various verticals of the globe. Over the years it has successfully established its dominance in various regions like Americas, Asia Pacific, Europe and Rest of the World.
Americas has the upper hand out of all the above-mentioned regions. It accounts for the maximum market shares. Its lead can be mainly attributed to a recent survey that suggested that nearly 7.8% of the population was struggling with asthma in US alone. Furthermore, this market will observe expansion due to the presence of major market players and higher investments in the healthcare sector.
Major key Players:
Leading players profiled in the respiratory inhalers market include Teva Pharmaceutical Industries Ltd, Propeller Health, GSK plc, Chiesi Farmaceuti S.p.A., Boehringer Ingelheim GmbH, AstraZeneca and Adherium limited.
December 2018- ResMed, a leader in out-of-hospital SaaS (software-as-a-service) business solutions and cloud connected medical device, announced its partnership with Propeller Health, leading digital therapeutics company to acquire health solutions for people suffering from asthma and COPD. The objective of this partnership is to augment people’s quality of life, save healthcare costs and reduce the impact of the debilitating respiratory disorders.
May 2018- Propeller Health has joined hands with Aptar Pharma in order to make digital medicines. Aptar Pharma will connect the drug dispensation devices such as injections and inhalers with Propeller’s software through sensors that will assist patients to manage pain, opioid addiction, and respiratory diseases better.
Access full report @ https://www.marketresearchfuture.com/reports/respiratory-inhalers-market-3110
Industry News:
March 27, 2018 – Adherium a renowned medical equipment manufacturer has bagged a crucial approval from the FDA. It got a heads up from FDA for its new product Smartinhaler sensor which is an aerosol asthma inhaler to be sold over the counter. This development is supposed to positively impact the market’s progression.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Related Reports:
Healthcare Supply Chain Management Market
Clinical Practice Management Market
